Measurement of antibodies against meningococcal capsular polysaccharides B and C in enzyme-linked immunosorbent assays: Towards an improved surveillance of meningococcal disease

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 3, 1997, Pages 345-351

  Andersen, Jesper ^a   Berthelsen, Lene ^a   Lind, Inga ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM CULTURE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0030927137     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.3.345-351.1997     Document Type: Article

References (28)

1. Arakere, G., and C. E. Frasch. 1991. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers. Infect. Immun. 59:4349-4356.
2. Begg, N. 1992. Reducing mortality from meningococcal disease. Br. Med. J. 305:133-134.
3. Brandt, B. L., F. A. Wyle, and M. S. Artenstein. 1972. A radioactive antigen-binding assay for Neisseria meningitidis polysaccharide antibody. J. Immunol. 108:913-920.
4. Carlone, G. M., C. E. Frasch, G. R. Siber, S. Quataert, L. L. Gheesling, S. H. Turner, B. D. Plikaytis, L. O. Helsel, W. E. DeWitt, W. F. Bibb, B. Swaminathan, G. Arakere, C. Thompson, D. Phipps, D. Madore, and C. V. Broome. 1992. Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J. Clin. Microbiol. 30:154-159.
5. Conolly, M., and N. D. Noah. 1995. Surveillance of bacterial meningitis in Europe 1994. King's College School of Medicine and Dentistry, Department of Public Health & Epidemiology, London, United Kingdom.
6. Devi, S. J., J. B. Robbins, and R. Schneerson. 1991. Antibodies to poly[(2-8)-alpha-N-acetylneuraminic acid] and poly[(2-9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1. Proc. Natl. Acad. Sci. USA 88:7175-7179.
7. Edwards, E. A., L. F. Devine, G. H. Sengbusch, and H. W. Ward. 1977. Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence. Scand. J. Infect. Dis. 9:105-110.
8. Finne, J., M. Leinonen, and P. H. Mäkelä. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet ii:355-357.
9. Gheesling, L. L., G. M. Carlone, L. B. Pais, P. F. Holder, S. E. Maslanka, B. D. Plikaytis, M. Achtman, P. Densen, C. E. Frasch, H. Käyhty, J. P. Mays, L. Neucioni, C. Peetors, D. C. Phipps, J. T. Poolman, E. Rosenqvist, G. R. Siber, B. Thiesen, J. Tai, C. M. Thompson, P. P. Vella, and J. D. Wenger. 1994. Multicenter comparison of Neisseria meningitidis serogroup C anticapsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J. Clin. Microbiol. 32:1475-1482.
10. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129:1327-1348.
11. Griffiss, J. M. 1995. Mechanisms of host immunity, p. 35-70. In K. Cartwright (ed.), Meningococcal disease. John Wiley & Sons, London, United Kingdom.
12. Griffiss, J. M., B. L. Brandt, D. D. Broud, D. K. Goroff, and C. J. Baker. 1984. Immune response of infants and children to disseminated infections with Neisseria meningitidis. J. Infect. Dis. 150:71-79.
13. Hansen, E. 1995. Meningococcal disease 1994. EPI-NEWS publication no. 36. Statens Serum Institut, Copenhagen, Denmark.
14. Hoiby, E. A., G. Bjune, L. O. Froholm, J. Eng, A. Halstensen, E. Rosenqvist, E. Ronnild, and E. Wedege. 1991. The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosis. NIPH Ann. 14:107-121.
15. Jackson, L. A., A. Schuchat, M. W. Reeves, and J. D. Wenger. 1995. Serogroup C meningococcal outbreaks in the United States: an emerging threat. JAMA 273:383-389.
16. Käyhty, H., H. Jousimies Somer, H. Peltola, and P. H. Mäkelä. 1981. Antibody response to capsular polysaccharides of groups A and C Neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease. J. Infect. Dis. 143:32-41.
17. Konradsen, H. B., U. B. Sorensen, and J. Henrichsen. 1993. A modified enzyme-linked immunosorbent assay for measuring type-specific anti-pneumococcal capsular polysaccharide antibodies. J. Immunol. Methods 164:13-20.
18. Kristensen, M. 1930. Die Komplementbindungsreaktion bei Gonorrhoe (Tecknik). Acta Pathol. Microbiol. Scand. 7:87.
19. Leinonen, M., and C. E. Frasch. 1982. Class-specific antibody response to group B Neisseria meningitidis capsular polysaccharide: use of polylysine prccoating in an enzyme-linked immunosorbent assay. Infect. Immun. 38: 1203-1207.
20. Romero, J. D., and I. Outschoorn. 1993. Selective biotinylation of Neisseria meningitidis group B capsular polysaccharide and application in an improved ELISA for detection of specific antibodies. J. Immunol. Methods 160:35-17.
21. Romero, J. D., and I. M. Outschoorn. 1994. Current status of meningococcal group B vaccine candidates: capsular or noncapsular? Clin. Microbiol. Rev. 7:559.
22. Salih, M. A., H. Fredlund, S. Hugosson, L. Bodin, and P. Olcen. 1993. Different seroprevalences of antibodies against Neisseria meningitidis serogroup A and Haemophilus infiuenzae type b in Sudanese and Swedish children. Epidemiol. Infect. 110:307-316.
23. Samuelsson, S., S. Gustavsen, and T. Ronne. 1991. Epidemiology of meningococcal disease in Denmark 1980-1988. Scand. J. Infect. Dis. 23:723-730.
24. Schwartz, B., P. S. Moore, and C. V. Broome. 1989. Global epidemiology of meningococcal disease. Clin. Microbiol. Rev. 2(Suppl.):S118-S124.
25. Sippel, J. E., and N. I. Girgis. 1991. Detection of IgM antibodies to Neisseria meningitidis group A polysaccharide in meningitis patients by direct and antibody capture enzyme-linked immunosorbent assays. Am. J. Trop. Med. Hyg. 45:676-682.
26. Sørensen, H. T., J. Møller-Petersen, H. Bygum Krarup, H. Pedersen, H. Hansen, and H. Hamburger. 1992. Early treatment of meningococcal disease. Br. Med. J. 305:774. (Letter.)
27. Weis, N., L. Berthelsen, and I. Lind. 1990. Serology in the diagnosis of meningococcal disease, abstr. 168. In Neisseriae - 1990 posters; VIIth Conference on Pathogenic Neisseriae, Berlin, Germany.
28. Yamasaki, R. 1993. Conformations of group B and C polysaccharides of Neisseria meningitidis and their epitope expression, p. 1-9. In J. Roth, U. Rutishauer, and F. A. Troy II (ed.), Polysialic acid from microbes to man. Birkhäuser Verlag, Basel, Switzerland.